Absorption-improving effects of chitosan oligomers based on their mucoadhesive properties: a comparative study on the oral and pulmonary delivery of calcitonin

References

• Bai SH, Thomas CD, Ahsan F. (2007). Dendrimer as a carrier for pulmonary delivery of enoxaparin, a low-molecular weight heparin. J Pharm Sci 96:2090–106
   PubMed Web of Science ®Google Scholar
• Di CG, Zambito Y, Zaino C. (2008). Polymeric enhancers of mucosal epithelia permeability: synthesis, transepithelial penetration-enhancing properties, mechanism of action, safety issues. J Pharm Sci 97:1652–80
   PubMed Web of Science ®Google Scholar
• Dong ZQ, Katsumi H, Sakane T, Yamamoto A. (2010). Effects of polyamidoamine (PAMAM) dendrimers on the nasal absorption poorly absorbable drugs in rats. Int J Pharm 393:244–52
   PubMed Web of Science ®Google Scholar
• Dong ZQ, Abdul HK, Gao Y, et al. (2011). Polyamidoamine dendrimers can improve the pulmonary absorption of insulin and calcitonin in rats. J Pharm Sci 100:1866–78
   PubMed Web of Science ®Google Scholar
• Dornish M, Aarnold M, Skaugrud O. (1996). Alginate and chitosan: biodegradable biopolymers in drug delivery systems. Eur J Pharm 182:21–3
   Google Scholar
• Enna SJ, Schanker LS. (1972). Absorption of drugs from the rat lung. Am J Physiol 223:1227–31
   PubMed Web of Science ®Google Scholar
• Feith G, Habib F, Okada N, et al. (2005). Nitric oxide donors can enhance the intestinal transport and absorption of insulin and [Asu1,7]-eel calcitonin in rats. J Control Release 106:287–97
   PubMed Web of Science ®Google Scholar
• Gao Y, He L, Katsumi H, et al. (2008). Improvement of intestinal absorption of insulin and water-soluble macromolecular compounds by chitosan oligomers in rats. Int J Pharm 358:70–8
   Web of Science ®Google Scholar
• Gupta S, Jain A, Chakraborty M, et al. (2013). Oral delivery of therapeutic proteins and peptides: a review on recent developments. Drug Deliv 20:237–46
   PubMed Web of Science ®Google Scholar
• Hagerstrom H, Edsman K. (2001). Interpretation of mucoadhesive properties of polymers gel preparations using a tensile strength method. J Pharm Pharmacol 53:1589–99
   PubMed Web of Science ®Google Scholar
• Hall DJ, Khutoryanskaya OV, Khutoryanskiy VV. (2011). Developing synthetic mucosa-mimetic hydrogels to replace animal experimentation in characterization of mucoadhesive drug delivery systems. Soft Matter 7:9620–3
   Web of Science ®Google Scholar
• He L, Gao Y, Lin YL, et al. (2007). Improvement of pulmonary absorption of insulin and other water-soluble compounds by polyamines in rats. J Control Release 1:94–101
   Web of Science ®Google Scholar
• Hirano S, Seino H, Akiyama Y, Nonaka I. (1990). Chitosan: a biocompatible material for oral and intravenous administration. In: Gebelein, CG, Dunn RL, eds. Progress in biomedical polymers. New York: Plenum Press, 283–9
   Google Scholar
• Huang AW, Su ZG, Li S, et al. (2014). Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers. Drug Deliv 21:388–96
   PubMed Web of Science ®Google Scholar
• Hussain A, Arnold JJ, Khan MA, Ahsan F. (2004). Absorption enhancers in pulmonary protein delivery. J Control Release 1:15–24
   Web of Science ®Google Scholar
• Illum L. (1998). Chitosan and its use a pharmaceutical excipient. Pharm Res 15:1236–331
   Web of Science ®Google Scholar
• Jackson SJ, Perkins AC. (2001). In vitro assessment of the mucoadhesion of cholestyramine to procine and human gastric mucosa. Eur J Pharm Biopharm 52:121–7
   PubMed Web of Science ®Google Scholar
• Jones DS, Woolfson AD, Brown AF. (1997). Textural, viscoelastic and mucoadhesive properties of pharmaceutical gels composed of cellulose polymers. Int J Pharm 151:223–33
   Web of Science ®Google Scholar
• Klausner EA, Zhang Z, Chapman RL, et al. (2010). Ultrapure chitosan oligomers as carriers for forneal gene transfer. Biomaterials 31:1814–20
   PubMed Web of Science ®Google Scholar
• Klausner EA, Zhang Z, Won SP, et al. (2012). Corneal gene delivery: chitosan oligomer as a carrier of CpG rich, CpG free or S/MAR plasmid DNA. J Gene Med 14:100–108
   PubMed Web of Science ®Google Scholar
• Li HY, Seville PC. (2010). Novel pMDI formulations for pulmonary delivery of proteins. Int J Pharm 1–2:73–8
   Web of Science ®Google Scholar
• Maher S, Leonard TW, Jacobsen J, Brayden DJ. (2009). Safety and efficacy and sodium caprate in promoting oral drug absorption: from in vitro to the clinic. Adv Drug Delivery Rev 61:1427–49
   PubMed Web of Science ®Google Scholar
• Mao SR, Bakowsky U, Jintapattanakit A, Kissel T. (2006). Self-assembled polyelectrolyte nanocomplexs between the chitosan derivatives and insulin. J Pharm Sci 95:1035–48
   PubMed Web of Science ®Google Scholar
• Millotti G, Perera G, Vigl C, et al. (2011). The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery. Drug Deliv 18:190–7
   PubMed Web of Science ®Google Scholar
• Na LN, Wang J, Wang LL, Mao SR. (2013). A novel permeation enhancer: N-succinyl chitosan on the intranasal absorption of isosorbide dinitrate in rats. Eur J Pharm Sci 48:301–306
   PubMed Web of Science ®Google Scholar
• Schipper NG, Olsson S, Hoogstraate JA, et al. (1997). Chitosan as absorption enhancers for poorly absorbable drugs 2: Mechanism of absorption enhancement. Pharm Res 14:923–9
   PubMed Web of Science ®Google Scholar
• Sogias IA, Williams AC, Khutoryanskiy VV. (2012). Chitosan-based mucoadhesive tables for oral delivery of ibuprofen. Int J Pharm 436:602–610
   PubMed Web of Science ®Google Scholar
• Sun W, Mao S, Wang YJ, et al. (2010). Bioadhesion and oral absorption of enoxaparin nanocomplexes. Int J Pharm 386:275–81
   PubMed Web of Science ®Google Scholar
• Thanou M, Verhoef JC, Junginger HE. (2001). Oral drug absorption enhancement by chitosan and its derivatives. Adv Drug Deliv Rev 52:117–26
   PubMed Web of Science ®Google Scholar
• Wang WX, Gao JQ, Liang WQ. (2011). Chitosan-coated liposomes for intracellular oligonucleotides delivery: characteristics and cell uptake behavior. Drug Deliv 18:208–14
   PubMed Web of Science ®Google Scholar
• Whitehead K, Karr N, Mitragotri S. (2008). Safe and effective permeation enhancers for oral drug delivery. Pharm Res 25:1782–8
   PubMed Web of Science ®Google Scholar
• Yamada K, Odomi M, Okada N, et al. (2005). Chitosan Oligomers as potential and safe absorption enhancers for improving the pulmonary absorption of Interferon-a in rats. J Pharm Sci 94:2432–40
   PubMed Web of Science ®Google Scholar
• Yamamoto A, Taniguchi T, Rikyuu K, et al. (1994). Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats. Pharm Res 11:1496–500
   PubMed Web of Science ®Google Scholar
• Yang TZ, Hussain A, Bai SH, et al. (2006). Positively charged polyethylenimines enhance nasal absorption of the negatively charge drug, low molecular weight heparin. J Control Research 115:289–97
   PubMed Web of Science ®Google Scholar